FR2809398B3 - Nouveaux composes heterocycliques et leur application a titre de medicaments - Google Patents

Nouveaux composes heterocycliques et leur application a titre de medicaments

Info

Publication number
FR2809398B3
FR2809398B3 FR0006535A FR0006535A FR2809398B3 FR 2809398 B3 FR2809398 B3 FR 2809398B3 FR 0006535 A FR0006535 A FR 0006535A FR 0006535 A FR0006535 A FR 0006535A FR 2809398 B3 FR2809398 B3 FR 2809398B3
Authority
FR
France
Prior art keywords
medicaments
application
heterocyclic compounds
novel heterocyclic
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0006535A
Other languages
English (en)
Other versions
FR2809398A1 (fr
Inventor
Serge Auvin
De Lassauniere Pierre Chabrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0006535A priority Critical patent/FR2809398B3/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to AT00974646T priority patent/ATE318809T1/de
Priority to CA2389685A priority patent/CA2389685C/fr
Priority to PCT/FR2000/003067 priority patent/WO2001032654A2/fr
Priority to EP00974646A priority patent/EP1233962B1/fr
Priority to MXPA02004442A priority patent/MXPA02004442A/es
Priority to AU12871/01A priority patent/AU781551B2/en
Priority to DE60026348T priority patent/DE60026348T2/de
Priority to CZ20021548A priority patent/CZ20021548A3/cs
Priority to HU0203183A priority patent/HUP0203183A3/hu
Priority to PT00974646T priority patent/PT1233962E/pt
Priority to PL355286A priority patent/PL200167B1/pl
Priority to ES00974646T priority patent/ES2259617T3/es
Priority to KR1020027005798A priority patent/KR100725198B1/ko
Priority to EP05077194A priority patent/EP1661564A1/fr
Priority to RU2002114696/04A priority patent/RU2260009C2/ru
Priority to NZ518420A priority patent/NZ518420A/en
Priority to BR0015315-0A priority patent/BR0015315A/pt
Priority to JP2001534805A priority patent/JP2003513092A/ja
Priority to IL14917700A priority patent/IL149177A0/xx
Priority to CNB008159262A priority patent/CN1317278C/zh
Priority to US10/111,994 priority patent/US6747024B1/en
Publication of FR2809398A1 publication Critical patent/FR2809398A1/fr
Priority to IL149177A priority patent/IL149177A/en
Priority to NO20022088A priority patent/NO20022088L/no
Priority to IS6371A priority patent/IS2297B/is
Publication of FR2809398B3 publication Critical patent/FR2809398B3/fr
Application granted granted Critical
Priority to HK03105058.5A priority patent/HK1052706B/zh
Priority to US10/803,387 priority patent/US20040180936A1/en
Priority to AU2005203713A priority patent/AU2005203713A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0006535A 1999-11-05 2000-05-23 Nouveaux composes heterocycliques et leur application a titre de medicaments Expired - Fee Related FR2809398B3 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR0006535A FR2809398B3 (fr) 2000-05-23 2000-05-23 Nouveaux composes heterocycliques et leur application a titre de medicaments
ES00974646T ES2259617T3 (es) 1999-11-05 2000-11-03 Compuestos heterociclicos y su aplicacion como medicamentos.
PCT/FR2000/003067 WO2001032654A2 (fr) 1999-11-05 2000-11-03 Nouveaux composes heterocycliques et leur application a titre de medicaments
EP00974646A EP1233962B1 (fr) 1999-11-05 2000-11-03 Composes heterocycliques et leur application a titre de medicaments
MXPA02004442A MXPA02004442A (es) 1999-11-05 2000-11-03 Nuevos compuestos heterociclicos y su uso como medicamentos.
AU12871/01A AU781551B2 (en) 1999-11-05 2000-11-03 Novel heterocyclic compounds and their use as medicines
BR0015315-0A BR0015315A (pt) 1999-11-05 2000-11-03 Compostos, medicamentos, composições farmacêuticas, utilização de compostos e produtos industriais
CZ20021548A CZ20021548A3 (cs) 1999-11-05 2000-11-03 Nové heterocyklické sloučeniny a jejich pouľití jako léků
HU0203183A HUP0203183A3 (en) 1999-11-05 2000-11-03 Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
PT00974646T PT1233962E (pt) 1999-11-05 2000-11-03 Compostos heterociclicos e a sua utilizacao como medicamentos
PL355286A PL200167B1 (pl) 1999-11-05 2000-11-03 Związki heterocykliczne o aktywności hamowania kalpain i/lub pułapkowania ROS, ich zastosowanie i kompozycje farmaceutyczne je zawierające oraz związki pośrednie
CA2389685A CA2389685C (fr) 1999-11-05 2000-11-03 Nouveaux composes heterocycliques et leur application a titre de medicaments
KR1020027005798A KR100725198B1 (ko) 1999-11-05 2000-11-03 신규 헤테로시클릭 화합물 및 의약으로서의 용도
EP05077194A EP1661564A1 (fr) 1999-11-05 2000-11-03 Nouveaux composés hétérocycliques et leur application à titre de médicaments
AT00974646T ATE318809T1 (de) 1999-11-05 2000-11-03 Heterocyclische verbindungen und ihre verwendung als medikamente
RU2002114696/04A RU2260009C2 (ru) 1999-11-05 2000-11-03 Новые гетероциклические соединения и их применение в качестве лекарственных средств
DE60026348T DE60026348T2 (de) 1999-11-05 2000-11-03 Heterocyclische verbindungen und ihre verwendung als medikamente
JP2001534805A JP2003513092A (ja) 1999-11-05 2000-11-03 新規複素環化合物及びその医薬としての使用
IL14917700A IL149177A0 (en) 1999-11-05 2000-11-03 Novel heterocyclic compounds and their use as medicines
CNB008159262A CN1317278C (zh) 1999-11-05 2000-11-03 新杂环化合物及它们作为药物的用途
US10/111,994 US6747024B1 (en) 1999-11-05 2000-11-03 Heterocyclic compounds and their use as medicines
NZ518420A NZ518420A (en) 1999-11-05 2000-11-03 Heterocyclic compounds having an inhibitory activity on calpains or a trapping activity on reactive oxygen species (ROS's) and their use as medicines
IL149177A IL149177A (en) 1999-11-05 2002-04-16 Heterocyclic compounds and their use as drugs
NO20022088A NO20022088L (no) 1999-11-05 2002-05-02 Nye heterocykliske forbindelser og deres anvendelse som medisiner
IS6371A IS2297B (is) 1999-11-05 2002-05-03 Nýjar fenóþíasínafleiður og notkun þeirra sem lyfja
HK03105058.5A HK1052706B (zh) 1999-11-05 2003-07-14 新雜環化合物及它們作為藥物的用途
US10/803,387 US20040180936A1 (en) 1999-11-05 2004-03-16 Heterocyclic compounds and their use as medicaments
AU2005203713A AU2005203713A1 (en) 1999-11-05 2005-08-18 New heterocyclic compounds and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0006535A FR2809398B3 (fr) 2000-05-23 2000-05-23 Nouveaux composes heterocycliques et leur application a titre de medicaments

Publications (2)

Publication Number Publication Date
FR2809398A1 FR2809398A1 (fr) 2001-11-30
FR2809398B3 true FR2809398B3 (fr) 2002-07-26

Family

ID=8850491

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0006535A Expired - Fee Related FR2809398B3 (fr) 1999-11-05 2000-05-23 Nouveaux composes heterocycliques et leur application a titre de medicaments

Country Status (1)

Country Link
FR (1) FR2809398B3 (fr)

Also Published As

Publication number Publication date
FR2809398A1 (fr) 2001-11-30

Similar Documents

Publication Publication Date Title
FR16C0042I1 (fr) Derives de composes heterocycliques et medicaments
FR2825705B1 (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2790473B1 (fr) Nouveaux composes et medicaments les contenant
FI991485A (fi) Uusi farmaseuttinen koostumus
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
NO20030418D0 (no) Nytt farmasöytisk preparat
DE60132108D1 (de) Gefriergetrocknetes pantoprazol-präparat und pantoprazol-injektion
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20015149D0 (no) Nytt farmasöytisk preparat
DZ3370A1 (fr) Composes de piperazine et piperidine
NO20015148L (no) Nytt farmasöytisk preparat
DE60020494D1 (de) Injektionskatheter
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20015104L (no) Nytt farmasöytisk preparat
MA25651A1 (fr) Composes caldilytiques
FR2809398B3 (fr) Nouveaux composes heterocycliques et leur application a titre de medicaments
IS6163A (is) Lyfjakomplex
NO20015105D0 (no) Nytt farmasöytisk preparat
FR2800737B1 (fr) Nouveaux composes heterocycliques et leur application a titre de medicaments
EE200300045A (et) Kristalne ravimaine
AR027062A1 (es) Paquete de cigarrillos
NO20021036L (no) Farmasöytisk preparat
FR2799461B1 (fr) Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2838443B1 (fr) Pentapeptides cycliques et leur preparation
FR2812546B1 (fr) Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments

Legal Events

Date Code Title Description
ST Notification of lapse